Chinese healthcare, biotech firms flock to Hong Kong for IPOs

Chinese healthcare, biotech firms flock to Hong Kong for IPOs

September yields at least 23 listing applications from mainland biotech firms eyeing the city’s lucrative fundraising market.

Biotech IPOs in Hong Kong far outpace the US, driven by China’s buzzy biotech sector

As biotech IPOs hit a record low in the US, more than 40 Chinese biopharma companies have filed to go public so far this year. That’s more than four times the number that have sought ...